Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Pioglitazone on T2DM Patients With COVID-19 (PIOQ8)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04604223
Recruitment Status : Recruiting
First Posted : October 27, 2020
Last Update Posted : March 17, 2021
Sponsor:
Collaborators:
Ministry of Health, Kuwait
Texas Diabetes Institute
Kuwait University
Information provided by (Responsible Party):
Dasman Diabetes Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 29, 2021
Estimated Study Completion Date : June 29, 2021